Jana Medical Company (TADAWUL:9616)

Saudi Arabia · Delayed Price · Currency is SAR

13.50

-0.69 (-4.86%)

Oct 1, 2025, 3:12 PM AST

Jana Medical Company Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-23.17	5.41	5.22
Depreciation & Amortization	0.33	0.38	0.22
Other Amortization	0	0	0
Loss (Gain) From Sale of Assets	0	-	-
Provision & Write-off of Bad Debts	8.14	3.18	0.65
Other Operating Activities	10.41	0.19	0.77
Change in Accounts Receivable	14.77	-30.88	-32.31
Change in Inventory	-1.1	8.74	-7.89
Change in Accounts Payable	-0.66	0.07	-0.09
Change in Other Net Operating Assets	-3.41	0.28	-2.98
Operating Cash Flow	5.33	-12.62	-36.41
Operating Cash Flow Growth	-	-	-

Investing Activities

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Capital Expenditures	-0.01	-0.16	-0.36
Sale of Property, Plant & Equipment	0	-	-
Sale (Purchase) of Intangibles	-0.03	-0.08	-0
Investing Cash Flow	-0.04	-0.24	-0.36

Financing Activities

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Short-Term Debt Issued	-	4.82	-
Long-Term Debt Issued	52	48.03	29.75
Total Debt Issued	52	52.85	29.75
Short-Term Debt Repaid	-4.88	-	-5.72
Long-Term Debt Repaid	-51.2	-44.88	-8.76
Lease Payments	-0.21	-0.26	-0.15
Total Debt Repaid	-56.09	-44.88	-14.47
Net Debt Issued (Repaid)	-4.08	7.97	15.28
Issuance of Common Stock	26.05	-	22.06
Other Financing Activities	-10.99	4.94	-
Financing Cash Flow	10.97	12.9	37.34

Net Cash Flow

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Cash Flow	16.26	0.05	0.57

Free Cash Flow

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Free Cash Flow	5.32	-12.78	-36.77
Free Cash Flow Growth	-	-	-
Free Cash Flow Margin	14.48%	-20.82%	-85.42%
Free Cash Flow Per Share	2.00	-4.97	-18.29
Levered Free Cash Flow	9.9	-8.58	-
Unlevered Free Cash Flow	14.74	-5.52	-
Free Cash Flow After Leases	5.11	-13.03	-36.92

Additional Metrics

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash Interest Paid	-	-	2.04
Change in Working Capital	9.6	-21.78	-43.27